MRIdian A3i MRI-Guided Radiation Therapy
MRIdian A3i Treatment Momentum
Installed systems
0
Patients treated
0
Disease sites
0
The Impact of MRIdian A3i
THIS IS WHAT YOU'VE BEENWAITING FOR
MRIdian A3i is the first MR-guided radiotherapy system with peer-reviewed evidence demonstrating reduced side effects and extended survival by decreasing treatment volumes and delivering ablative doses. Learn the impact of MRIdian A3i through stories told firsthand by patients and physicians.
Expanding Cancer Care
MORE PATIENTS. MORE PROOF.MORE PROMISE.
Many hospitals worldwide have built successful MRIdian programs to expand cancer care with many centers investing in additional systems to meet patient demand. Research how MRIdian offers personalized cancer treatment for pancreas, prostate, lung, liver, breast, and oligometastatic cancers.
Discover MRIdian A3i
SEE WHAT YOU'VE BEENMISSING
Traditional imaging technology associated with radiation delivery systems provides limited visualization of soft tissue, causing the use of implanted markers which can shift during treatment. With MRIdian A3i, diagnostic-quality MRI imaging enables precise contouring and real-time tissue tracking and automated beam control to ensure the precise delivery of the dose to the target.